
A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.
Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.

Published: October 16th 2023 | Updated:

Published: May 1st 2009 | Updated: